Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL517632 | 0.76 | ALOX5 (0.41) | AKR1C1KMT2AALDH1A1OPRK1CYP1A2 | |
| SCHEMBL29985406 | 0.76 | ALDH1A1 (0.32) | AKR1C1KMT2AGAAALDH1A1OPRK1 | |
| SCHEMBL6942516 | 0.76 | SLC6A2 (0.42) | OPRK1 | |
| SCHEMBL5815457 | 0.73 | CHRM2 (0.40) | KMT2AMEN1ALDH1A1TSHRCYP2D6 | |
| SCHEMBL6472115 | 0.72 | MME (0.37) | KMT2AMEN1OPRK1 | |
| SCHEMBL516114 | 0.72 | SRC (0.41) | AKR1C1CYP1A2CYP2D6 | |
| SCHEMBL516716 | 0.72 | LMNA (0.37) | CYP1A2CYP2D6 | |
| SCHEMBL18342994 | 0.71 | ALDH1A1 (0.40) | KMT2AALDH1A1TSHRCYP2D6 | |
| SCHEMBL30816986 | 0.70 | CNR2 (0.39) | KMT2AMEN1ALDH1A1OPRK1CYP1A2 | |
| SCHEMBL30851542 | 0.70 | CNR2 (0.39) | KMT2AMEN1ALDH1A1OPRK1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2214487-A1 | NOVEL SEH INHIBITORS AND THEIR USE | GlaxoSmithKline LLC (US) | 2010-08-11 | — | — | EP | disclosed |
| WO-2009049157-A1 | NOVEL SEH INHIBITORS AND THEIR USE | SMITHKLINE BEECHAM CORPORATION (US) | 2009-04-16 | — | — | WO | disclosed |